ProSciento Becomes a California-Wide Sponsor of JDRF’s One Walks
SAN DIEGO, November 30, 2021 – ProSciento, Inc., a specialty clinical research organization (CRO) focused exclusively on metabolic diseases, is pleased to announce that it has become the first California-wide […]
ProSciento Appoints Lynn Rudolph as Vice President of Human Resources
SAN DIEGO, November 10, 2021 – ProSciento, Inc., a specialty clinical research organization (CRO) focused exclusively on metabolic diseases, today announced the appointment of Lynn Rudolph as Vice President of […]
ProSciento Co-Hosts the 4th Annual NASH Roundtable Virtual Forum
November 1, 2021 ‒ ProSciento, Inc. and the NASH Roundtable™, with co-hosts Antaros Medical AB and Nordic Bioscience,A/S, will host the 4th Annual NASH Roundtable Forum on November 18, 2021 […]
ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science
SAN DIEGO, July 8, 2021 – ProSciento, Inc., a specialty clinical research organization (CRO) focused exclusively on diabetes, obesity, non-alcoholic steatohepatitis (NASH), and related metabolic diseases, announces the appointment of […]
ProSciento Closes Growth Financing from 1315 Capital
SAN DIEGO and PHILADELPHIA, September 10, 2020 /Businesswire/ – ProSciento, Inc., a leading specialty clinical research organization (CRO) focused on non-alcoholic steatohepatitis (NASH), diabetes, obesity, and related metabolic diseases, announced […]
ProSciento Appoints Stephen Mullennix as Chief Financial Officer
SAN DIEGO, September 1, 2020 – ProSciento, Inc., a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases, today announced the appointment of […]
ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California
SAN DIEGO, June 15, 2020 – ProSciento, Inc., a clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity, and related metabolic diseases, announced today that its clinical research unit […]
ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH)
SAN DIEGO, February 6, 2020 /PRNewswire/ – ProSciento, Inc., a clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases, announced today a strategic partnership with […]
ProSciento to Present at the Diabetes Technology Annual Meeting
SAN DIEGO, November 12, 2019 – ProSciento, Inc., a clinical research organization (CRO) exclusively focused on diabetes, NASH, obesity and related metabolic diseases, will present clinical research data at the […]
ProSciento to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting
SAN DIEGO, August 5, 2019 – ProSciento, Inc., a clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases, will present clinical research data at the […]